Back to results
US 10,206,971 B2Granted
Suspensions of cyclosporin A form 2
AssigneeAllergan, Inc.
InventorsAnuradha V. Gore, Prem Swaroop Mohanty, E. Quinn Farnes
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods of formulating cyclosporin A Form 2.
Claims3
A method of treating a condition selected from dry eye, blepharitis, meibomian gland disease, impaired corneal sensitivity, allergic conjunctivitis, atopic keratoconjunctivitis, vernal keratoconjunctivitis, and pterygia, the method comprising the step of administering to a patient having such a condition a formulation comprising particles of cyclosporin A form 2 and a vehicle, wherein the average size (d90) of the particles is less than about 10 μm.
Dependencies are inferred from the claim text.